Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EO-1 ethanolamine oleate sclerotherapy study for difficult-to-resect venous malformations
jRCT2051200046Active, not recruiting
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of ethanolamine oleate in venous malformation (VM). Primary endpoint: Primary efficacy endpoint. Started Jan 2021; status: active, not recruiting.
02
Drugs
ethanolamine oleate
03
Conditions
venous malformation (VM)
Beyond the preview
Go deeper on jRCT2051200046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2051200046.